{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:06:45Z","timestamp":1773184005121,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.humimm.2020.12.007","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T22:09:56Z","timestamp":1609279796000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves\u2019 disease and Hashimoto\u2019s thyroiditis in the Japanese population"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-8138","authenticated-orcid":false,"given":"Masahito","family":"Katahira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetada","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hodai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Miwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2020.12.007_b0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7","article-title":"Primary role of the HLA class II DRB1*0301 allele in graves disease","volume":"95","author":"Zamani","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.humimm.2020.12.007_b0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF03343819","article-title":"HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves\u2019 disease","volume":"24","author":"Philippou","year":"2001","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.humimm.2020.12.007_b0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/gene.2008.26","article-title":"Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves\u2019 disease","volume":"9","author":"Zeitlin","year":"2008","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.humimm.2020.12.007_b0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.1991.tb00309.x","article-title":"HLA Associations with Hashimoto's thyroiditis","volume":"34","author":"Tendon","year":"1991","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.humimm.2020.12.007_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0039.2008.01182.x","article-title":"Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes\u2019 associations of Hashimoto\u2019s thyroiditis in a Greek population","volume":"73","author":"Kokaraki","year":"2009","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.humimm.2020.12.007_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/tan.12536","article-title":"Determination of HLA\u2010A, \u2010C, \u2010B, \u2010DRB1 allele and haplotype frequency in Japanese population based on family study","volume":"85","author":"Ikeda","year":"2015","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/j.humimm.2020.12.007_b0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.humimm.2010.05.020","article-title":"Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population","volume":"71","author":"Katahira","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.12.007_b0040","first-page":"55","article-title":"Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children","volume":"63","author":"Iwama","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.humimm.2020.12.007_b0045","first-page":"253","article-title":"Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population","volume":"64","author":"Hashimoto","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.humimm.2020.12.007_b0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1507\/endocrj.41.599","article-title":"HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ","volume":"41","author":"Katsuren","year":"1994","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.humimm.2020.12.007_b0055","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1210\/jc.2013-2841","article-title":"Identification of Independent Susceptible and Protective HLA Alleles in Japanese Autoimmune Thyroid Disease and Their Epistasis","volume":"99","author":"Ueda","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.humimm.2020.12.007_b0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0198-8859(92)90101-R","article-title":"HLA-A and DPB1 loci confer susceptibility to Grave's disease","volume":"35","author":"Dong","year":"1992","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2020.12.007_b0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1507\/endocrj1954.29.423","article-title":"HLA-DR antigens in Japanese with hashimoto's thyroiditis and graves' disease.","volume":"29","author":"Azuma","year":"1982","journal-title":"Endocrinol. Japon"},{"issue":"2","key":"10.1016\/j.humimm.2020.12.007_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0198-8859(94)00089-9","article-title":"HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis","volume":"42","author":"Wan","year":"1995","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2020.12.007_b0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humimm.2013.01.026","article-title":"Effect of human leukocyte antigen class II genes on Hashimoto\u2019s thyroiditis requiring replacement therapy with levothyroxine in the Japanese population","volume":"74","author":"Katahira","year":"2013","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2020.12.007_b0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/426947","article-title":"Regression Mapping of Association between the Human Leukocyte Antigen Region and Graves Disease","volume":"76","author":"Simmonds","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2020.12.007_b0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","article-title":"Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease","volume":"5","author":"Ban","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2020.12.007_b0090","unstructured":"Japan Thyroid Association, Guidelines for the Diagnosis of Graves' Disease. http:\/\/www.japanthyroid.jp\/en\/guidelines.html#Gra, (accessed 2 July 2020)."},{"key":"10.1016\/j.humimm.2020.12.007_b0095","unstructured":"Japan Thyroid Association, Guidelines for the Diagnosis of Chronic Thyroiditis. http:\/\/www.japanthyroid.jp\/en\/guidelines.html#Chr, (accessed 2 July 2020)."},{"issue":"3","key":"10.1016\/j.humimm.2020.12.007_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2009.06.007","article-title":"The human leukocyte antigen class II gene has different contributions to autoimmune Type 1 diabetes with or without autoimmune thyroid disease in the Japanese population","volume":"85","author":"Katahira","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.humimm.2020.12.007_b0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2015.12.006","article-title":"Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline","volume":"77","author":"Pappas","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.12.007_b0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Statist. Soc. B."},{"issue":"6","key":"10.1016\/j.humimm.2020.12.007_b0115","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.humimm.2005.03.001","article-title":"Association of HLA-DR and -DQ Genes with Graves Disease in Koreans","volume":"66","author":"Park","year":"2005","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2020.12.007_b0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08820139.2014.886261","article-title":"The clinical value of human leukocyte antigen HLA-DRB1 subtypes associated to Graves\u2019 disease in Romanian population","volume":"43","author":"Martin","year":"2014","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.humimm.2020.12.007_b0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0090-1229(90)90009-F","article-title":"HLA class I and II antigens in South African Blacks with Graves' disease","volume":"54","author":"Omar","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.humimm.2020.12.007_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1994.tb02444.x","article-title":"The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects","volume":"40","author":"Cavan","year":"1994","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.humimm.2020.12.007_b0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-0039.1989.tb01734.x","article-title":"HLA Bw46 and DR9 associations in Graves\u2019disease of Chinese patients are age- and sex-related","volume":"34","author":"Yeo","year":"1989","journal-title":"Tissue Antigens"},{"issue":"1-2","key":"10.1016\/j.humimm.2020.12.007_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/08820139609059294","article-title":"HLA-DQ3 is Associated with Graves\u2019 Disease in African-Americans","volume":"25","author":"Ofosu","year":"1996","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2020.12.007_b0145","first-page":"336","article-title":"Association of HLA-DR tissue types with Graves' disease in Taiwan","volume":"88","author":"Tsai","year":"1989","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.humimm.2020.12.007_b0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0039.2012.01920.x","article-title":"The HLA-DRB1 gene and Graves disease in Taiwanese children: a case-control and family-based study","volume":"80","author":"Wu","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.12.007_b0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.gene.2017.11.057","article-title":"Interaction of HLA-DRB1* alleles and CTLA4 (+ 49 AG) gene polymorphism in Autoimmune Thyroid Disease","volume":"642","author":"Ramgopal","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.humimm.2020.12.007_b0160","first-page":"227","article-title":"Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population","volume":"79","author":"Yanagawa","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.humimm.2020.12.007_b0165","doi-asserted-by":"crossref","unstructured":"P.L. Chen, C.S. Fann, C.C. Chu, C.C. Chang, S.W. Chang, H.Y. Hsieh, M. Lin, W.S. Yang, T.C. Chang, Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles, PLoS One 6 (2011) e16635.","DOI":"10.1371\/journal.pone.0016635"},{"issue":"1","key":"10.1016\/j.humimm.2020.12.007_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1399-0039.2005.00498.x","article-title":"The association between HLA class II haplotype with Graves' disease in Thai population","volume":"67","author":"Wongsurawat","year":"2006","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.humimm.2020.12.007_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000331134","article-title":"Association of HLA Alleles with Autoimmune Thyroid Disease in Korean Children","volume":"76","author":"Cho","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.humimm.2020.12.007_b0180","doi-asserted-by":"crossref","unstructured":"S. Yasunaga, A. Kimura, K. Hamaguchi, K.S. Ronningen, T. Sasazuki, Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM), Tissue Antigens 47 (1996) 37\u201348.","DOI":"10.1111\/j.1399-0039.1996.tb02512.x"},{"key":"10.1016\/j.humimm.2020.12.007_b0185","first-page":"94","article-title":"Resistance to autoimmune thyroid disease is associated with HLA-DQ","volume":"78","author":"Tamai","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.humimm.2020.12.007_b0190","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/clinem\/dgz164","article-title":"Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity","volume":"105","author":"Frommer","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.humimm.2020.12.007_b0195","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ng.3353","article-title":"Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk","volume":"47","author":"Hu","year":"2015","journal-title":"Nat. Genet."},{"issue":"37","key":"10.1016\/j.humimm.2020.12.007_b0200","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1073\/pnas.0806584105","article-title":"Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice","volume":"105","author":"Menconi","year":"2008","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920304419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920304419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:53:08Z","timestamp":1759319588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885920304419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0198885920304419"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.12.007","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves\u2019 disease and Hashimoto\u2019s thyroiditis in the Japanese population","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}